Bookmark and Share
NR5A1 (geneid:2516) - Gene BioActivity Data
Also known as: RP11-101K10.1, AD4BP, ELP, FTZ1, FTZF1, POF7, SF-1, SF1, SPGF8, SRXY3.
BioActivity Outcomes:
Probe(4)
 
 
Active(6114)
 
 
Inactive(130106)
 
 
Unspecified(55)
 
 
BioAssay Types:
Screening(134661)
 
 
 
Confirmatory(1406)
 
 
 
Literature(122)
 
 
 
 
Summary(29)
 
 
 
BioActivity Types:
IC50(604)
 
 
 
EC50(69)
 
 
 
 
Substance Types:
Chemical(136272)
 
 
 
 
 
RNAi(7)
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 25    Data Row: 136279   Total Pages: 2726   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID7969543]
[CID4076092]
Summary of probe development efforts to identify inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1). [AID1844, Type: summary] [gi:216409744]
View
2
[SID7970631]
[CID4289057]
Summary of probe development efforts to identify inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1). [AID1844, Type: summary] [gi:216409744]
View
3
[SID46499821]
[CID4131581]
Summary of probe development efforts to identify inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1). [AID1844, Type: summary] [gi:216409744]
View
4
[SID46499828]
[CID4329551]
Summary of probe development efforts to identify inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1). [AID1844, Type: summary] [gi:216409744]
View
5
[SID103501333]
[CID24825422]
EC50 0.01Binding affinity to human SF1 by FRET-based peptide recruitment assay [AID271722, Type: Literature] [gi:3121738]
View
6
[SID103501357]
[CID24825437]
EC50 0.011Binding affinity to human SF1 by FRET-based peptide recruitment assay [AID271722, Type: Literature] [gi:3121738]
View
7
[SID103501390]
[CID24825427]
EC50 0.014Binding affinity to human SF1 by FRET-based peptide recruitment assay [AID271722, Type: Literature] [gi:3121738]
View
8
[SID103501320]
[CID11132282]
EC50 0.03Binding affinity to human SF1 by FRET-based peptide recruitment assay [AID271722, Type: Literature] [gi:3121738]
View
9
[SID131274842]
[CID52936713]
EC50 0.03162Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
10
[SID131282925]
[CID52937353]
EC50 0.03981Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
11
[SID103501444]
[CID24825431]
EC50 0.03981Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
12
[SID103501444]
[CID24825431]
EC50 0.043Binding affinity to human SF1 by FRET-based peptide recruitment assay [AID271722, Type: Literature] [gi:3121738]
View
13
[SID26730794]
[CID9566279]
IC50 0.04918Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651968, Type: confirmatory] [gi:20070193]
View
14
[SID103501294]
[CID10883540]
EC50 0.054Binding affinity to human SF1 by FRET-based peptide recruitment assay [AID271722, Type: Literature] [gi:3121738]
View
15
[SID131272872]
[CID52937034]
EC50 0.0631Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
16
[SID131272874]
[CID52937355]
EC50 0.0631Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
17
[SID131272875]
[CID54580360]
EC50 0.0631Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
18
[SID131286941]
[CID52937449]
EC50 0.0631Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
19
[SID131276887]
[CID52937035]
EC50 0.0631Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
20
[SID131274840]
[CID52936934]
EC50 0.07943Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
21
[SID131284888]
[CID52937450]
EC50 0.07943Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
22
[SID49829017]
[CID4905846]
IC50 0.09321Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651968, Type: confirmatory] [gi:20070193]
View
23
[SID57256177]
[CID4789729]
IC50 0.10489Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651968, Type: confirmatory] [gi:20070193]
View
24
[SID49825032]
[CID8069390]
IC50 0.11201Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651968, Type: confirmatory] [gi:20070193]
View
25
[SID103501321]
[CID24825434]
EC50 0.12Binding affinity to human SF1 by FRET-based peptide recruitment assay [AID271722, Type: Literature] [gi:3121738]
View
26
[SID131276891]
[CID52937246]
EC50 0.12589Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
27
[SID103501422]
[CID24825428]
EC50 0.13Binding affinity to human SF1 by FRET-based peptide recruitment assay [AID271722, Type: Literature] [gi:3121738]
View
28
[SID103501431]
[CID24825429]
EC50 0.13Binding affinity to human SF1 by FRET-based peptide recruitment assay [AID271722, Type: Literature] [gi:3121738]
View
29
[SID103501366]
[CID24825425]
EC50 0.13Binding affinity to human SF1 by FRET-based peptide recruitment assay [AID271722, Type: Literature] [gi:3121738]
View
30
[SID103501356]
[CID24825424]
EC50 0.14Binding affinity to human SF1 by FRET-based peptide recruitment assay [AID271722, Type: Literature] [gi:3121738]
View
31
[SID26727554]
[CID9566278]
IC50 0.14276Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651968, Type: confirmatory] [gi:20070193]
View
32
[SID49643057]
[CID952237]
IC50 0.14768Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651968, Type: confirmatory] [gi:20070193]
View
33
[SID131276888]
[CID52937037]
EC50 0.15849Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
34
[SID131276890]
[CID52937140]
EC50 0.15849Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
35
[SID131282926]
[CID52937354]
EC50 0.15849Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
36
[SID103501294]
[CID10883540]
EC50 0.15849Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
37
[SID103501344]
[CID24825423]
EC50 0.17Binding affinity to human SF1 by FRET-based peptide recruitment assay [AID271722, Type: Literature] [gi:3121738]
View
38
[SID49726028]
[CID6484709]
IC50 0.17772Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651968, Type: confirmatory] [gi:20070193]
View
39
[SID103501454]
[CID24825432]
EC50 0.18Binding affinity to human SF1 by FRET-based peptide recruitment assay [AID271722, Type: Literature] [gi:3121738]
View
40
[SID131284890]
[CID52937452]
EC50 0.19953Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
41
[SID131282923]
[CID52937141]
EC50 0.19953Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
42
[SID131282920]
[CID52936928]
EC50 0.19953Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
43
[SID131282921]
[CID52936931]
EC50 0.19953Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
44
[SID131276892]
[CID52937350]
EC50 0.19953Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
45
[SID131276886]
[CID52936930]
EC50 0.25119Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
46
[SID131274843]
[CID52936819]
EC50 0.25119Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
47
[SID131272873]
[CID52937249]
EC50 0.25119Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
48
[SID26727363]
[CID9566277]
IC50 0.3092Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput dose response assay to identify inverse agonists of the Steroidogenic Factor 1 Nuclear Receptor (SF1; NR5A1) [AID651968, Type: confirmatory] [gi:20070193]
View
49
[SID131278915]
[CID52937451]
EC50 0.31623Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View
50
[SID131280925]
[CID52937356]
EC50 0.31623Agonist activity at human SF-1 assessed as DAX1 1-23 peptide recruitment by TR-FRET assay relative to control [AID593529, Type: Literature] [gi:3121738]
View